Most Popular Vector Database on GitHub Powers Thousands of AI Applications Worldwide Zilliz, creator of the leading open-source vector database Milvus, today announced that Milvus has achieved 35,000 stars on GitHub, establishing it as the most popular vector database platform globally. The milestone reinforces Milvus's dominant market position in the rapidly expanding vector database sector, […]
Survival in 20 patients with MSS/pMMR mCRC at a median follow-up of 15.4 months was 40% at 12 months; median survival is currently 11.3 months Survival has currently reached plateau, with 34% (7/20) of patients still alive 80% of patients treated with EO4010/nivolumab showed specific immune responses against tumor associated antigens targeted by the OncoMimics(TM)
Enterome presents positive Phase 1/2 MSS/pMMR metastatic colorectal cancer data in patients treated with EO4010 OncoMimics(TM) immunotherapy plus nivolumab at ASCO 2025 GlobeNewswire May 30, 2025 Survival in 20 patients with MSS/pMMR mCRC at a median follow-up of 15.4 months was 40% at 12 months; median survival is currently 11.3 months Survival has currently reached
KUALA LUMPUR, MALAYSIA / ACCESS Newswire / May 30, 2025 / Audio industry trailblazer JBL is raising the bar once again with the introduction of the JBL Tour One M3 Smart Tx , the ultimate blend of innovative audio technology and seamless connectivity with the first JBL Smart Tx audio transmitter. This latest addition to
NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=150891&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
X-Origin AI Launches Its First AI Companion Robot Yonbo on Kickstarter-Meet Your Most Understanding Digital Life Partner for Lifelong Companionship. X-ORIGIN-AI specializes in the R&D of consumer-grade AI robotics, breaking the constraints of AI as a mere tool and advancing human-machine interaction from utility to emotional connection. Addressing the needs of users across all life
NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your UnitedHealth Group Incorporated (NYSE:UNH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unitedhealth-group-incorporated-lawsuit-submission-form?prid=150890&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=150889&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=150888&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=150887&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call